LUNG Pulmonx Corp

$2.27 -0.88%

Updated 17 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

Pulmonx Corp (LUNG) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $97 million. Shares last traded at $2.27, 21.4% below their 52-week high. Over the past year the stock is up 36.0%. Net profit margin is -55.0%, below the peer median of -9.3%. Revenue grew 8.0% year over year.

Market Cap

$97M

Shares Out

42.9M

EPS (TTM)

$-2.71

P/E Ratio

—

P/S Ratio

1.11

P/B Ratio

2.48

Dividend / Share

—

Dividend Yield

—

52-Week High

$2.88

52-Week Low

$1.14

Volume

22,654

Avg Vol (3m)

45,131.746

Performance

-6.79%

+14.97%

+39.81%

+40.68%

YTD

-1.52%

+36.04%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

55.42

SMA (50)

$1.81

SMA (200)

$1.68

Price vs SMA50

+25.23%

Price vs SMA200

+35.18%

ATR (14)

$0.17

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$87M

Net Income

$-48M

Gross Margin

77.1%

Operating Margin

-53.0%

Net Margin

-55.0%

Return on Equity

-122.8%

Return on Assets

-41.9%

Current Ratio

4.32

Debt / Equity

0.96

Revenue Growth (YoY)

+8.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.56	2026-08-04
Q1 2026	$-0.33	2026-05-04
FY 2025	$-1.33	2026-03-10
Q3 2025	$-1.08	2025-11-12
Q2 2026	$-0.74	2026-08-04
Q1 2026	$-0.36	2026-05-04

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

LUNG vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 17 d ago

P/S vs peers

1.11 / 2.94 med

-62% discount

Net margin vs peers

-55.0% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.